Technology
New evidence shows tirzepatide and semaglutide strongly protect the heart
2025-11-21 23:10
906 views
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabe...
A massive real-world study comparing tirzepatide and semaglutide reveals both drugs deliver strong, early cardiovascular protection—reducing heart attack, stroke, and death in adults with type 2 diabetes. While companies have claimed large differences favoring their own medications, researchers found only modest distinctions between the two blockbuster GLP-1 drugs.
Related Articles
Intel might return to Apple laptops, but not the way you think
1002 views
Bears vault to top seed in the NFC following Rams loss
474 views
Colts RB Jonathan Taylor stats, numbers today in Week 13 vs. Houston Texans
677 views
NFL Winners and Losers: After Rams loss, it's hard to find any reliable Super Bowl contenders
645 views